Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals.

Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P.

Atherosclerosis. 2009 Jan;202(1):289-95. doi: 10.1016/j.atherosclerosis.2008.03.014. Epub 2008 Mar 25.


The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study.

Mitchell BD, McArdle PF, Shen H, Rampersaud E, Pollin TI, Bielak LF, Jaquish C, Douglas JA, Roy-Gagnon MH, Sack P, Naglieri R, Hines S, Horenstein RB, Chang YP, Post W, Ryan KA, Brereton NH, Pakyz RE, Sorkin J, Damcott CM, O'Connell JR, Mangano C, Corretti M, Vogel R, Herzog W, Weir MR, Peyser PA, Shuldiner AR.

Am Heart J. 2008 May;155(5):823-8. doi: 10.1016/j.ahj.2008.01.019. Epub 2008 Mar 5.


Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study.

Loria CM, Liu K, Lewis CE, Hulley SB, Sidney S, Schreiner PJ, Williams OD, Bild DE, Detrano R.

J Am Coll Cardiol. 2007 May 22;49(20):2013-20. Epub 2007 May 4.


Determinants of coronary artery and aortic calcification in the Old Order Amish.

Post W, Bielak LF, Ryan KA, Cheng YC, Shen H, Rumberger JA, Sheedy PF 2nd, Shuldiner AR, Peyser PA, Mitchell BD.

Circulation. 2007 Feb 13;115(6):717-24. Epub 2007 Jan 29.


Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study.

Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, Mitchell BD, Wozniak MA, Stern BJ, Sorkin JD, McArdle PF, Naj AC, Xu Q, Gibbons GH, Kittner SJ.

Hum Mol Genet. 2006 Aug 15;15(16):2468-78. Epub 2006 Jul 11.


Variance decomposition of apolipoproteins and lipids in Danish twins.

Fenger M, Benyamin B, Schousboe K, Sørensen TI, Kyvik KO.

Atherosclerosis. 2007 Mar;191(1):40-7. Epub 2006 May 26. Erratum in: Atherosclerosis. 2008 Oct;200(2):451. Benyamin, Beben [added].


Effect of lipid modification on progression of coronary calcification.

McCullough PA.

J Am Soc Nephrol. 2005 Nov;16 Suppl 2:S115-9. Review.


Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.

Austin MA, Hutter CM, Zimmern RL, Humphries SE.

Am J Epidemiol. 2004 Sep 1;160(5):407-20. Review.


Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Purcell S, Cherny SS, Sham PC.

Bioinformatics. 2003 Jan;19(1):149-50.


Heritabilities of apolipoprotein and lipid levels in three countries.

Beekman M, Heijmans BT, Martin NG, Pedersen NL, Whitfield JB, DeFaire U, van Baal GC, Snieder H, Vogler GP, Slagboom PE, Boomsma DI.

Twin Res. 2002 Apr;5(2):87-97.


The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.

Borén J, Ekström U, Agren B, Nilsson-Ehle P, Innerarity TL.

J Biol Chem. 2001 Mar 23;276(12):9214-8. Epub 2000 Dec 13.


Implementing a unified approach to family-based tests of association.

Laird NM, Horvath S, Xu X.

Genet Epidemiol. 2000;19 Suppl 1:S36-42.


Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.

Tybjaerg-Hansen A, Steffensen R, Meinertz H, Schnohr P, Nordestgaard BG.

N Engl J Med. 1998 May 28;338(22):1577-84.


Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.

Ludwig EH, Hopkins PN, Allen A, Wu LL, Williams RR, Anderson JL, Ward RH, Lalouel JM, Innerarity TL.

J Lipid Res. 1997 Jul;38(7):1361-73.


Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries.

Hansen PS, Defesche JC, Kastelein JJ, Gerdes LU, Fraza L, Gerdes C, Tato F, Jensen HK, Jensen LG, Klausen IC, Faergeman O, Schuster H.

Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):741-7.


Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study.

Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW.

Circulation. 1996 Nov 1;94(9):2159-70.


High prevalence of familial defective apolipoprotein B-100 in Switzerland.

Miserez AR, Laager R, Chiodetti N, Keller U.

J Lipid Res. 1994 Apr;35(4):574-83.


Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Friedewald WT, Levy RI, Fredrickson DS.

Clin Chem. 1972 Jun;18(6):499-502. No abstract available.

Supplemental Content

Support Center